318 related articles for article (PubMed ID: 24122800)
1. Comparison of maternal serum PlGF and sFlt-1 between pregnancies with and without fetal hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
Prenat Diagn; 2013 Dec; 33(13):1272-5. PubMed ID: 24122800
[TBL] [Abstract][Full Text] [Related]
2. Second trimester maternal serum inhibin-A in fetal anemia secondary to hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1005-9. PubMed ID: 24107149
[TBL] [Abstract][Full Text] [Related]
3. Comparison of red blood cell hematology among normal, alpha-thalassemia-1 trait, and hemoglobin Bart's fetuses at mid-pregnancy.
Srisupundit K; Piyamongkol W; Tongsong T
Am J Hematol; 2008 Dec; 83(12):908-10. PubMed ID: 18932192
[TBL] [Abstract][Full Text] [Related]
4. Second trimester maternal serum alpha-fetoprotein (MSAFP) as predictor of fetal hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
Prenat Diagn; 2014 Dec; 34(13):1277-82. PubMed ID: 25046597
[TBL] [Abstract][Full Text] [Related]
5. Second trimester maternal serum markers and a predictive model for predicting fetal hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
J Matern Fetal Neonatal Med; 2013 Jan; 26(2):146-9. PubMed ID: 22989193
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cardiac troponin T and N-terminal pro-B-type natriuretic peptide between fetuses with hemoglobin Bart's disease and nonanemic fetuses.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
Prenat Diagn; 2014 Sep; 34(9):864-9. PubMed ID: 24733401
[TBL] [Abstract][Full Text] [Related]
7. Placental thickness at mid-pregnancy as a predictor of Hb Bart's disease.
Tongsong T; Wanapirak C; Sirichotiyakul S
Prenat Diagn; 1999 Nov; 19(11):1027-30. PubMed ID: 10589053
[TBL] [Abstract][Full Text] [Related]
8. Identification of fetuses with hemoglobin Bart's disease using middle cerebral artery peak systolic velocity.
Srisupundit K; Piyamongkol W; Tongsong T
Ultrasound Obstet Gynecol; 2009 Jun; 33(6):694-7. PubMed ID: 19350531
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum hCG, PAPP-A and AFP as predictors of hemoglobin Bart disease at mid-pregnancy.
Tongprasert F; Wanapirak C; Tongsong T
Prenat Diagn; 2011 May; 31(5):430-3. PubMed ID: 21312197
[TBL] [Abstract][Full Text] [Related]
10. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
[TBL] [Abstract][Full Text] [Related]
11. Fetal splenic artery peak velocity (SPA-PSV) at mid-pregnancy as a predictor of Hb Bart's disease.
Tongsong T; Piyamongkol W; Tongprasert F; Srisupundit K; Luewan S
Ultraschall Med; 2011 Jan; 32 Suppl 1():S41-5. PubMed ID: 21225551
[TBL] [Abstract][Full Text] [Related]
12. Screening for hemoglobin Bart's disease among fetuses at risk at mid-pregnancy using the fetal cardiac diameter to biparietal diameter ratio.
Thathan N; Traisrisilp K; Luewan S; Srisupundit K; Tongprasert F; Tongsong T
BMC Pregnancy Childbirth; 2014 Jul; 14():230. PubMed ID: 25028081
[TBL] [Abstract][Full Text] [Related]
13. Fetal anemia causes placental and maternal cellular damage: a lesson from fetal hemoglobin Bart's disease.
Luewan S; Apaijai N; Chattipakorn N; Chattipakorn S; Tongsong T
Placenta; 2024 Apr; 149():72-77. PubMed ID: 38531214
[TBL] [Abstract][Full Text] [Related]
14. Analysis of fetal blood using capillary electrophoresis system: a simple method for prenatal diagnosis of severe thalassemia diseases.
Srivorakun H; Fucharoen G; Sae-Ung N; Sanchaisuriya K; Ratanasiri T; Fucharoen S
Eur J Haematol; 2009 Jul; 83(1):57-65. PubMed ID: 19226360
[TBL] [Abstract][Full Text] [Related]
15. Prenatal diagnosis of haemoglobin Bart's disease by cordocentesis at 12-14 weeks--experience with the first 59 cases.
Lam YH; Tang MH
Prenat Diagn; 2000 Nov; 20(11):900-4. PubMed ID: 11113892
[TBL] [Abstract][Full Text] [Related]
16. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
[TBL] [Abstract][Full Text] [Related]
17. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
[TBL] [Abstract][Full Text] [Related]
18. Early pregnancy maternal and fetal angiogenic factors and fetal and childhood growth: the Generation R Study.
Bergen NE; Bouwland-Both MI; Steegers-Theunissen RP; Hofman A; Russcher H; Lindemans J; Jaddoe VW; Steegers EA
Hum Reprod; 2015 Jun; 30(6):1302-13. PubMed ID: 25854264
[TBL] [Abstract][Full Text] [Related]
19. Splenic circumference at midpregnancy as a predictor of hemoglobin Bart's disease among fetuses at risk.
Srisupundit K; Tongprasert F; Luewan S; Sirichotiyakul S; Tongsong T
Gynecol Obstet Invest; 2011; 72(1):63-7. PubMed ID: 21389673
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of fetal hemoglobin Bart's for evaluation of fetal α-thalassemia syndromes: application to prenatal characterization of fetal anemia caused by undiagnosed α-hemoglobinopathy.
Singha K; Yamsri S; Chaibunruang A; Srivorakun H; Sanchaisuriya K; Fucharoen G; Fucharoen S
Orphanet J Rare Dis; 2022 Feb; 17(1):45. PubMed ID: 35144630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
